Panel Discussion: Potency Assay Development Over the Development Lifecycle
Time: 4:30 pm
day: Conference Day One - PM
Details:
• Should we start potency assay development early? Or should we wait until clearer signals emerge later in subsequent phases
that a therapy is likely to be safe and efficacious?
• How do we translate early phase potency assays into late phase assays?
• At what stage do you begin to qualify and validate?
